Press Releases

Stay Updated

Press Releases

STATEMENT: P4AD Congratulates Karikó And Weissman For Nobel Prize And Salutes The NIH For Funding The Research That Made It Possible

Moderna, BioNTech And Pfizer Took Interest Only After The Key Discovery Funded By U.S. Taxpayers Through NIH Patients And All Americans Should Be Getting A Better Deal On Vaccines They Paid To Make Possible    WASHINGTON, D.C. — The following statement was issued by David Mitchell, a cancer patient and founder of Patients For Affordable Drugs […]

Press Releases

Report Update Reveals Drug Industry Funding And Control Of Groups Purporting To Represent Patients

WASHINGTON, D.C. — A new report update of P4AD’s research into drug industry influence – Hiding In Plain Sight – documents the structure and conduct of three organizations that have garnered increased attention recently purporting to represent the interests of patients, but which in reality serve the interests of those who profit from prescription drugs. […]

Press Releases

STATEMENT: After Years Of Advocacy, Patients Will See Long-Awaited Relief From Eli Lilly’s Insulin Price Cut

WASHINGTON, D.C. — The following statement was issued by Merith Basey, executive director of Patients For Affordable Drugs, in response to Eli Lilly and Company’s announcement to lower some of the company’s insulin prices by 70% and cap out-of-pocket costs at $35 per month: “Eli Lilly’s new insulin prices and caps will deliver long-awaited relief […]

Press Releases

ICYMI: Q&A With P4AD’s Executive Director Merith Basey

WASHINGTON, D.C. — Merith Basey, P4AD’s new executive director, fielded questions from P4AD’s patient community in a virtual Q&A yesterday. The forum was moderated by New Jersey patient advocate Lisa Ann Wetzel-Trainor, who lives with PTSD, fibromyalgia, and ADHD, and has been a strong advocate with P4AD for years. Over the past few weeks, patient advocates in 34 states submitted over […]

Press Releases

STATEMENT: Unjustified Price Of New ALS Treatment Reinforces Fact That Our Drug Pricing System Fails The People It Is Supposed To Serve – Patients

WASHINGTON, D.C. — The following statement was issued by David Mitchell, a cancer patient and founder and president of Patients For Affordable Drugs, in response to the pricing of Relyvrio following the Food and Drug Administration’s approval of the drug combination to treat amyotrophic lateral sclerosis (ALS): “The price of the newly approved drug combination […]

Press Releases

Merith Basey Named Executive Director Of Patients For Affordable Drugs

In The Third Year Of The Pandemic And As Americans Grapple With Record Inflation, Big Pharma Continues To Raise Prices And Exploit Patients WASHINGTON, D.C. —  Merith Basey, MSc, has been named executive director of the bipartisan advocacy organization, Patients For Affordable Drugs and its sister organization Patients For Affordable Drugs Now. Basey arrives at […]